Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Blood Specimen Collection × Clear all

Phase

Phase NA 7 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Colorectal Neoplasms 3 Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 High Grade Neuroendocrine Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Glioblastoma 1 Cytomegalovirus Infections 1 Colonic Neoplasms 1

Interventions

Temozolomide 136 Bevacizumab 75 Radiotherapy 67 Magnetic Resonance Spectroscopy 21 Irinotecan 18 pembrolizumab 16 Radiation 16 Lomustine 16 Carmustine 15 Surgical Procedures, Operative 11 Nivolumab 10 Erlotinib Hydrochloride 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Aminolevulinic Acid 9 Specimen Handling 8 Carboplatin 8 Cilengitide 7 Sunitinib 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Radiosurgery 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Filgrastim 5 Etoposide 5 Celecoxib 5 Topotecan 4 Tamoxifen 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01071837 2015-06-16

APG101 in Glioblastoma

Apogenix AG

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡